RUNX1 and myeloid leukemia: As AML1-ETO is associated with myeloid leukemia and has been shown to inhibit granulocytic differentiation [9, 42, 43], we examined its effect on myeloid development in our iPSC model by adding dox at various time points during hematopoietic differentiation.